Scientists search for keys to unlock immune attack on rare adrenal cancer
NCT ID NCT00457587
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is not testing a new drug, but rather doing the early science needed to develop one. Researchers are looking for the right targets (antigens) on adrenocortical carcinoma cells and studying how the tumor suppresses the immune system. The goal is to find a way to create a vaccine or immunotherapy for this rare and aggressive cancer. The study includes 150 people with the cancer and healthy volunteers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could identify targets for a future vaccine or immunotherapy for adrenocortical carcinoma.
What could go wrong
This is a very early, preclinical study. It is not testing a treatment on patients, so it may not lead to a usable therapy. The findings may not translate into clinical benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUSHING'S SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dept. of Medicine I, University of Wuerzburg
Würzburg, 97080, Germany